Stephen A. Harrison, MD, is the medical director and chairman of Pinnacle Clinical Research, internationally known researcher on liver diseases including the clinical trials for resmetirom, and visiting professor of hepatology at the Radcliffe Department of Medicine at the University of Oxford. Double board certified in internal medicine and gastroenterology, he practices in San Antonio.
The most prevalent condition worldwide is metabolic dysfunction-associated steatotic liver disease (MASLD), which replaces the term nonalcoholic fatty liver disease…
